CLEC12A/MICL/CLL-1, His, Cynomolgus
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.
| ¥3400 在线订购包邮(港澳台除外) | |
| Z03962-100 | |
|
|
|
|
|
|
|
|
|
| 咨询产品问题 | |